CHARLOTTE, N.C, Nov. 2, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced the appointment of William D. Schwieterman, M.D., to the newly created position of Chief Medical Officer. Dr. Schwieterman, who resigned his seat on Chelsea’s Board of Directors to assume the position, will be responsible for medical and regulatory affairs, and will report to Simon Pedder, Ph.D., Chelsea’s President and Chief Executive Officer.
